NCT05121285

Brief Summary

While delivery of an FMT-treatment to the cecum is visualized in a lower GI-endoscopy, it is uncertain whether delivery by enema distributes the FMT to the proximal segments of the colon. Positioning of the patient during the enema procedure may improve distribution to the proximal colon. Differences in distribution may explain the wide effect range and inferiority when enema is compared to delivery by lower GI endoscopy. Thus, in this study we will compare the distribution of FMT from delivery by lower GI endoscopy versus enema with and without positioning of the patient. We will use contrast fluid as a surrogate liquid for FMT to project the distribution on colon X-ray pictures. To our knowledge this is not done in any previous study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2021

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 16, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2022

Completed
Last Updated

June 6, 2022

Status Verified

October 1, 2021

Enrollment Period

7 months

First QC Date

November 3, 2021

Last Update Submit

June 1, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of cecum projection after CF delivery by lower GI endoscopy versus enema with positioning versus enema without positioning of the participants.

    Two radiologist determine the projection each colon X-ray picture by identifying segments where the gut mucosa is coated with contrast fluid and/or segments with contrast fluid in the lumen. The radiologist is blinded to which delivery method is used.

    10 minutes after contrast fluid delivery

Secondary Outcomes (1)

  • Proportion of transverse colon projection after CF delivery by the lower GI endoscopy versus enema with positioning versus enema without positioning of the participants.

    10-20 minutes after contrast fluid delivery

Study Arms (1)

Contrast fluid by lower GI endoscopy and enema with and without positioning

EXPERIMENTAL

There is a washout period of at least four weeks between the two interventions (delivery by lower GI endoscopy and enema)

Other: Delivery of contrast fluid by lower GI endoscopyOther: Delivery of contrast fluid by enema with and without positioning

Interventions

Each participant will receive one delivery of 440 ml contrast fluid by lower GI endoscopy to the cecum of the colon. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. An colon X-ray is obtained within 10 minutes after the contrast fluid is delivered. The participants is in a supine position fram delivery and until the colon x-ray is obtained.

Contrast fluid by lower GI endoscopy and enema with and without positioning

Each participant will receive one delivery of 440 ml contrast fluid by enema. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. The enema procedure includes: 1. The participant lies on his/her left side in neutral position when the enema is delivered 2. X-ray of the colon is obtained with the participant lying on his/her back. 3. The participant is positioned back to his/her left sided position and tilted in a Trendelenburg position. The position is held for two minutes 4. The participant is turned to an abdominal position while the bed remains tilted in Trendelenburg position. 5. Participant turne to the right side. When positioned the bed is tilted the opposite way (anti-Trendelenburg.) The position is held for two minutes. 6. A second colon X-ray is obtained after the participants has rested for ten minutes in a supine neutral position

Contrast fluid by lower GI endoscopy and enema with and without positioning

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for colonoscopy at the medical department at UNN Harstad
  • Able to complete the positioning procedure during the enema

You may not qualify if:

  • Confirmed malignancy
  • Inflammatory bowel disease
  • Referral highly suspicious of cancer, inflammatory bowel disease or obstructive GI disease
  • Contraindications for rectal catheter insertion (including known damage to pelvic floor, sphincter or the pudendal nerve)
  • Use of anticoagulants. Use of acetylsalicylic acid is allowed
  • Symptomatic cardiovascular or lung disease
  • Kidney failure
  • Known allergic reaction to any component in Liquid Polibar Plus
  • Pregnant, lactating or planning pregnancy
  • Asthma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of North Norway, Harstad

Harstad, Troms, 9406, Norway

Location

Related Publications (1)

  • Skjevling LK, Hanssen HM, Valle PC, Goll R, Juul FE, Arlov O, Johnsen PH. Colonic distribution of FMT by different enema procedures compared to colonoscopy - proof of concept study using contrast fluid. BMC Gastroenterol. 2023 Oct 23;23(1):363. doi: 10.1186/s12876-023-02979-x.

MeSH Terms

Interventions

Patient Positioning

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Peter H Johnsen, MD PhD

    University Hospital of North Norway

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2021

First Posted

November 16, 2021

Study Start

October 25, 2021

Primary Completion

May 18, 2022

Study Completion

May 18, 2022

Last Updated

June 6, 2022

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

Study protocol with statistical analysis plan will be uploaded to the ClinicalTrials.gov web site.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Within 2021

Locations